-
European Patent - EP 21306670.7 - 2021
Derivatives of Nifuroxazide for use in the treatment of mitochondrial disorders and neurodegenerative diseases.
-
SQSTM1 and its use in cancer therapy
Nathalie YAZBECK, Amine BELAID, Grégoire D’ANDREA, Iris GROSJEAN, Paul HOFMAN, Baharia MOGRABI
2021
EP20306577.6 -
Method for identifying gene products involved in incomplete response of drug sensitive cell populations
Jérémie Roux Agnès Paquet Mickael Meyer Luis Pereira
2021
WO2021058503A1
-
Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration
Sophie LAGET, Patrizia Paterlini-Brechot, Paul Hofman, Thierry CAPIOD
2020
EP3351935B12013 CA US RU CN EP WO JP EP BR RU CA MX ES CN AU EP 2014 IL 2015 HK 2018 AU JP 2020 US
-
Know-how DSO2019003244
The know-how DSO2019003244 is protected by an "envelope Soleau" / INPI
Inventors: Stéphanie Barnay-Verdier, Paola Furla
-
Know-how DSO2019013787
The know-how DSO2019013787, concerning a strategy for the identification of marine bioactive compounds, is protected by an "envelope Soleau" / INPI
Inventor: Eric Röttinger
-
P2rx7 modulators in therapy
Valérie Vouret Laetitia Douguet Alina Ghinet Germain Homerin Benoît Guy Marie Rigo Davy Jérémy Baudelet Xavier Dezitter Régis Millet Christophe Furman
2019
WO2019185868A1
-
Methods and compositions for treating skin afflictions
Inventor: Chloé Féral, Floriane Tissot, Laurence Cailleteau, Soline Estrach
Date de dépôt : 02 May 2018
Numéro de dépôt : EP18170458.6
-
Control of cell-type specific enhancer function
to be filed
-
The TRF2-SIRT3 axis in aging : methods and compositions for treating degenerative muscular and/or neurological conditions or diseases
Inventor: Eric Gilson
Numéro de dépôt (déposés le 27 Mars 2017): EP17305352.1 et EP17305351.3
-
Method for determining responsiveness to vandetanib in a patient suffering from medullary thyroid carcinoma
Brest P (Co-PI), Lassalle S, Zangari J, Mari B, Hofman P(Co-PI)
PCT/EP2017/052168
-
Tumoral Deconvolution
Malot C, Brest P
PCT/EP2017/058983
-
Method and kit for reprogramming somatic cells -
Inventors: Dmitry Bulavin, Doria FILIPPONI
Patent ID: WO 2016142427A1
-
Methods for diagnosing and treating a pathology associated with a synonymous mutation occurring within a gene of interest.
Principal inventors: Brest P (PI),. P. Hofman, B. Mograbi
WO2011045349A3.
-
A novel methodology to predict the response to HER2 bloking agent treatment in cancer
Gilles Pages
Patent ID: FR1155128
-
Method for determining a predisposition to basal cell carcinoma and for screening treatments thereof
Alexandre Valin, Thierry Magnaldo
Patent ID: WO 2010015618 A1
-
Method for determining the efficiency of a cancer treatment
Patrick Brest, Paul Hofman, Baharia Mograbi
Patent ID: WO 2011067346 A1
